Abound Wealth Management’s Pediatrix Medical MD Stock Holding History

Abound Wealth Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-17	Closed	-$198	–	1311
2024 Q3	$198	Sell	17 -12	-41%	-$113	﹤0.01%	1169
2024 Q2	$219	Hold	29	–	–	﹤0.01%	1087
2024 Q1	$291	Hold	29	–	–	﹤0.01%	1148
2023 Q4	$270	Buy	+29	New	+$300	﹤0.01%	1207

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Abound Wealth Management's MD Position: Q4 2024 in Review

Abound Wealth Management sold out of Pediatrix Medical (MD) in Q4 2024, closing a stake of 17 shares — an estimated $198 sold.

Abound Wealth Management first reported a position in MD in Q4 2023 and held it in 4 quarters. The position peaked at $291 in Q1 2024. 229 funds tracked by Wall St. Rank hold MD as of Q4 2024.

Abound Wealth Management reported no remaining Pediatrix Medical position as of Q4 2024 after selling out during the quarter.
Abound Wealth Management sold 17 Pediatrix Medical shares in Q4 2024, an estimated $198.
Abound Wealth Management first reported a position in Pediatrix Medical in Q4 2023 and held it in 4 quarters.
Abound Wealth Management's Pediatrix Medical position peaked at $291 in Q1 2024.
229 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2024.

Based on Abound Wealth Management's 13F filing for Q4 2024, filed 13 Jan 2025.